The use of Cardioxan as a cardioprotective agent during antitumor chemotherapy

Saved in:
Bibliographic Details
Published inTerapevtic̆eskii arhiv Vol. 66; no. 7; p. 54
Main Authors Lichinitser, M R, Vyshinskaia, G V, Min'kov, E D, Nakhalova, T A, Odzharova, A A, Garin, A M
Format Journal Article
LanguageRussian
Published Russia (Federation) 1994
Subjects
Adult
Antineoplastic Combined Chemotherapy Protocols - adverse effects
Breast Neoplasms - drug therapy
Cardiomyopathies - chemically induced
Cardiomyopathies - prevention & control
Cardiovascular Agents - therapeutic use
Cyclophosphamide - administration & dosage
Cyclophosphamide - adverse effects
Doxorubicin - administration & dosage
Doxorubicin - adverse effects
Drug Evaluation
Drug Interactions
Female
Fluorouracil - administration & dosage
Fluorouracil - adverse effects
Heart - drug effects
Humans
Middle Aged
Razoxane - therapeutic use
Remission Induction
Online AccessGet more information

Cover

More Information
ISSN:0040-3660